Tongling Jieya Biologic Technology Co., Ltd. (SHE:301108)
China flag China · Delayed Price · Currency is CNY
27.43
-0.15 (-0.54%)
At close: Apr 15, 2026

SHE:301108 Revenue

In the year 2025, Tongling Jieya Biologic Technology had annual revenue of 772.01M CNY with 41.02% growth. Tongling Jieya Biologic Technology had revenue of 207.24M in the quarter ending December 31, 2025, with 48.58% growth.

Revenue
772.01M
Revenue Growth
+41.02%
P/S Ratio
4.00
Revenue / Employee
1.25M
Employees
618
Market Cap
3.09B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025772.01M224.56M41.02%
Dec 31, 2024547.45M-75.14M-12.07%
Dec 31, 2023622.59M-43.98M-6.60%
Jan 1, 2023666.56M-317.89M-32.29%
Jan 1, 2022984.45M241.44M32.49%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition